Table 1.
The clinical presentations, treatments, and outcomes of cases with late-onset CblC deficiency.
Patient No. [Reference] | Diagnose age | Clinical symptoms | MRI or EMG results | Serum Hcy levels (μM/L) | Gene mutations | Outcome |
---|---|---|---|---|---|---|
1 (our patient) | 29 | Cognitive decline, cannot recognize family members, inaccurate answers and often non-sense | Symmetrical bilateral cerebellar lesions with Gd enhancement | 178.41 | c.484G>A/c.658_660del | Improved |
2 (4) | 11 | Learning difficulties Behavioral changes Ataxia and myoclonic jerks |
Dilation of subarachnoid Space frontoparietally |
225 | – | Improved |
3 (13) | 33 | Insomnia, exaggerated Expression |
Mild diffuse atrophy of cerebral cortex | 65 | c.482G>A/c.658_660del | Improved |
4 (14) | 19 | Posture change | Hyperintensity in the cerebellum and right basal ganglia, with modest cerebrum atrophy | 69.5 | c.482G>A/c.445_446del | Improved |
5 (13) | 29 | Irritability, euphoria Cognitive impairment |
Mild diffuse atrophy of cerebral cortex | 115.3 | c.482G>A/c.658_660del | Improved |
6 (10) | 11 | Clinical cognitive Deficit, limb weakness |
Peripheral nerve damage | 103.3 | c.609G>A | – |
7 (10) | 18 | Abnormal gait | Mild peripheral nerve damage | 61.4 | c.609G>A/ c.482G>A | – |